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Height has been used for more than a century as a model by which to understand quantitative genetic variation in
humans. We report that the entire genome appears to contribute to its additive genetic variance. We used genotypes
and phenotypes of 11,214 sibling pairs from three countries to partition additive genetic variance across the genome.
Using genome scans to estimate the proportion of the genomes of each chromosome from siblings that were identical
by descent, we estimated the heritability of height contributed by each of the 22 autosomes and the X chromosome.
We show that additive genetic variance is spread across multiple chromosomes and that at least six chromosomes (i.e.,
3, 4, 8, 15, 17, and 18) are responsible for the observed variation. Indeed, the data are not inconsistent with a uniform
spread of trait loci throughout the genome. Our estimate of the variance explained by a chromosome is correlated with
the number of times suggestive or significant linkage with height has been reported for that chromosome. Variance due
to dominance was not significant but was difficult to assess because of the high sampling correlation between additive
and dominance components. Results were consistent with the absence of any large between-chromosome epistatic effects.
Notwithstanding the proposed architecture of complex traits that involves widespread gene-gene and gene-environment
interactions, our results suggest that variation in height in humans can be explained by many loci distributed over all
autosomes, with an additive mode of gene action.
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Research into the genetics of complex traits has moved
from the estimation of genetic variance in populations to
the detection and identification of variants that are as-
sociated with or directly cause variation. The standard par-
adigm has been to perform linkage studies in pedigrees,
followed by fine-mapping or candidate-gene studies with
the use of association. Recently, genomewide association
(GWA) studies, which rely on linkage disequilibrium be-
tween observed and causal variants, have become a real-
ity—in particular, for the study of common disease in hu-
man populations.1–4 The success of both linkage and
association studies depends on the frequency and distri-
bution of individual gene effects in the population. Rare
variants with large effects can most readily be mapped in
pedigrees, whereas common variants with moderate ef-
fects can be mapped using an association study. Multiple
rare variants in the same gene, each with a moderate effect
on the phenotype, can be detected using linkage studies
but would be hard to find in an association study.
Despite the large research effort in the past decade or
so, the nature of complex-trait variation—in terms of the
number of causal variants, their frequency in the popu-
lation, and the size of their effects—is still largely un-
known.5 Emerging evidence suggests that there are com-
mon variants with effects large enough to be detected for
a range of phenotypes across a number of species, but the
number of identified causal variants remains small.6,7
Other evidence suggests that multiple rare variants in the
same gene may segregate in the population, each with an
effect large enough to increase susceptibility to disease.8
In human populations, there has frequently been incon-
sistency of linkage to disease and quantitative phenotypes
across multiple samples and populations, with few ex-
amples of clear-cut replication. One possible explanation
is that, for most phenotypes, the effects of causal variants
are too small to be detected by linkage—that is, that most
studies have been underpowered. Association analyses are
much more powerful for detecting small effects but, again,
are dependent on the actual distribution of effect sizes.
Recent reports of associated and replicated SNPs from
GWA studies show that the effect sizes of individual com-
mon variants are typically small.1–4 Both linkage and as-
sociation studies suffer from a multiple-testing problem,
because they are generally hypothesis generating. There
is also a conceptual problem with the null hypothesis in
nearly all gene-mapping studies. The null hypothesis for
a test at a given location in the genome is that there is
no genetic variation associated with that location, despite
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the fact that we know that there is heritability, often con-
siderable, for the phenotype in question. Hence, a priori,
the null hypothesis cannot be true for all test locations.
This assumption is particularly worrisome for linkage
studies because of the strong linkage disequilibrium with-
in families, such that many linked genes of small effects
would result in false evidence of a major gene of large
effect.9 We recently showed that a number of these prob-
lems disappear if the emphasis is on estimation of variance
rather than on hypothesis testing.10
The actual genomewide relationship between pairs of
relatives varies because of segregation and can be esti-
mated using dense genetic markers for each pair. For full
siblings, for example, the average proportion of the ge-
nome shared identical by descent (IBD) is 50%, with a
range of ∼38% to ∼62%.10 By calculating the covariance
between the proportion of the genome shared and the
similarity of siblings for the phenotype, we were able to
estimate the genetic variance free from assumptions
about nongenetic sources of resemblance between rela-
tives.10 In this study, we apply the principle of chromo-
some- and genomewide-realized relationships10,11 to par-
tition genetic variance across the genome. We use a very
large sample of sibling pairs with genomewide marker ge-
notypes, a well-studied12 quantitative phenotype in hu-
mans (i.e., height), and the independent segregation of
chromosomes, to partition genetic variation across chro-
mosomes. We show that at least six chromosomes are re-
sponsible for genetic variation but that the hypothesis
that all chromosomes contribute variation cannot be re-
jected. We find no evidence of dominance or epistatic
variation. Thus, our data are consistent with a large num-
ber of underlying variants acting additively across all chro-
mosomes to affect height in humans.
The data comprised quasi-independent sibling pairs
(QISPs) from three studies in Australia (AU), the United
States (US), and the Netherlands (NL). All individuals were
of European descent. Pairs of MZ twins were excluded, but
QISPs, including a single MZ individual, were maintained.
Descriptions of the pedigrees, phenotypes, and genotypes
have all been given elsewhere.10,13–15 In brief, for each of
the three samples, QISPs were created from pairs of sib-
lings within a nuclear family. Pairs were included if they
had both phenotypic and genomewide genotypic infor-
mation, with a minimum of 210 microsatellite markers
per individual and an average of 1400 markers for each
of the studies.10,13–15 Height measurements were adjusted
for sex and for age at measurement, and standardized re-
siduals (Z scores) were calculated for each individual for
each sample separately, to avoid the influence of hetero-
geneous variances across populations. There were 5,952,
3,996, and 1,266 QISPs for the AU, US, and NL samples,
respectively, with a total sample size of 11,214. There were
1,936 brother-brother pairs, 4,011 sister-sister pairs, and
5,267 brother-sister pairs. After adjustment for sex and
age, the sibling correlations for the AU, US, and NL sam-
ples were 0.432, 0.502, and 0.451, respectively, and the
sibling correlation in the entire sample was 0.461. The
brother-brother, sister-sister, and brother-sister correla-
tions in the entire sample, after adjustments for age (and
for the mean difference in sex in the brother-sister pairs),
were 0.494, 0.479, and 0.435, respectively.
Additive coefficients of relationship were calculated us-
ing Merlin16 for each chromosome and genomewide for
all three samples, as described elsewhere.10 For the X chro-
mosome, IBD probabilities were estimated using MINX.
The genetic length of the chromosomes was taken from
independent pedigree data.17 We estimated from the
marker data the proportions of individual chromosomes
and of the genome as a whole that are shared IBD between
all 11,214 pairs of siblings.10,13,14 These proportions are co-
efficients of additive relationship, which are, on average,
0.5 for full siblings but which vary considerably around
their expectation, both between chromosomes for the
same full-sib pair and between full-sib pairs for the same
chromosome.10,18 The meanSD of genomewide additive
relationships in our sample of 11,214 sibling pairs was
0.49940.036 and the range was 0.309 to 0.644, consis-
tent with previous results and with theory.10
Variance components were estimated by maximum like-
lihood, as implemented in the statistical package Mx19 and
described elsewhere.10 Mixed linear models were fitted, in-
cluding nongenetic family effects, chromosome and ge-
nomewide additive genetic effects, and residual effects. We
first estimated genetic variance associated with the entire
genome, by fitting a model that estimated the covariation
between phenotypic similarity and the coefficient of ad-
ditive relationship. For this whole-genome analysis, we
confirmed our previous results,10 which were based on a
smaller data set of 4,919 pairs from only one source of
data. The estimate of heritability for stature from genome-
wide IBD from the sample of 11,214 sibling pairs was 0.86
(95% CI 0.49–0.95; ). The estimate of the pro-P ! .00001
portion of phenotypic variation due to nongenetic family
effects was 0.03 ( ), which is statistically nonsig-Pp .38
nificant. In addition to the genomewide additive effect,
we fitted a genomewide dominance effect, using the
probability of sharing two alleles IBD, averaged across
the genome.10 The estimated proportions of variance due
to additive and dominance effects were 0.699 and 0.160,
respectively, but the dominance component was not
significantly different from zero ( ). However, sta-Pp .35
tistical power to separate these effects is low in our sibling-
pair design, since the genomewide additive and domi-
nance coefficients are highly correlated ( ;rp 0.911 np
), as predicted by theory.1011,214
After the genomewide analyses, we estimated genetic
variance associated with individual chromosomes, using
chromosomewide coefficients of additive relationship.
The proportion of additive genetic variance explained by
a particular chromosome was estimated in two ways—first,
by fitting a full model that included effects due to a single
chromosome and a reduced model in which no chro-
mosomal effects were fitted, and, second, by fitting a full
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Table 1. Estimates of Variance Proportions from Single-Chromosome
Analyses and a Joint Analysis of All 22 Autosomes
Chromosome
Single-Chromosome Analyses
Combined-Chromosome
Analysis
a2f b2hi
c2e LRTd P 2hi LRT
e P
1 .4285 .0607 .5108 1.201 .137 .0633 1.418 .117
2 .4525 .0131 .5344 .065 .399 .0097 .037 .424
3 .4023 .1134 .4843 5.704 .008 .1160 6.269 .006
4 .4036 .1124 .4840 5.938 .007 .1082 5.705 .008
5 .4458 .0264 .5278 .319 .286 .0196 .191 .500
6 .4336 .0506 .5158 1.294 .128 .0508 1.370 .500
7 .4284 .0616 .5100 2.019 .078 .0630 2.230 .068
8 .4234 .0708 .5058 2.778 .048 .0856 4.172 .021
9 .4482 .0216 .5302 .277 .299 .0325 .663 .500
10 .4590 .0000 .5410 .000 .500 .0000 .000 .500
11 .4590 .0000 .5410 .000 .500 .0000 .000 .500
12 .4365 .0451 .5184 1.121 .145 .0489 1.434 .500
13 .4545 .0089 .5366 .056 .406 .0006 .000 .500
14 .4427 .0323 .5250 .728 .197 .0185 .246 .500
15 .4241 .0703 .5056 3.353 .034 .0760 4.028 .022
16 .4556 .0069 .5375 .035 .426 .0180 .251 .308
17 .4023 .1142 .4834 9.019 .001 .1124 8.967 .001
18 .4237 .0703 .5060 3.753 .026 .0622 3.013 .041
19 .4437 .0309 .5253 .759 .192 .0317 .840 .500
20 .4575 .0031 .5395 .008 .464 .0037 .012 .456
21 .4590 .0000 .5410 .000 .500 .0000 .000 .500
22 .4590 .0000 .5410 .000 .500 .0000 .000 .500
Total … .9126 … 38.427 … .9205 40.846 …
a Proportion of variance due to sibling resemblance not accounted for by single-
chromosomal genetic effects.
b Proportion of variance due to additive genetic effects on the chromosome.
c Proportion of variance due to individual environmental effects.
d The likelihood-ratio test (LRT) statistic from comparing a full model fitting three
variance components with a reduced model fitting two variance components. The P
value was calculated assuming that the LRT statistic is distributed as 0 or , each2x1
with a probability of 1/2.
e The LRT statistic from comparing a full model fitting 24 variance components (22
additive genetic, 1 common environmental, and 1 residual) with a reduced model fitting
23 variance components, by dropping the ith additive genetic-variance component.
The P value was calculated in the same way as that in the single-chromosome analyses.
model containing effects for all 22 autosomes and a re-
duced model that fitted 21 autosomes only. Table 1 shows
that, for the individual-chromosome analyses, 6 of 22 es-
timates of chromosomal heritability were significantly dif-
ferent from zero at and of these 3 at . TheP ! .05 P ! .01
six most significant chromosomes were, in order of the
size of the test statistic, 17, 4, 3, 18, 15, and 8. This order
is not the same as that of estimated chromosomal heri-
tability, because SEs of estimates are larger for longer chro-
mosomes.10 The estimate of the proportion of variance due
to nongenetic family effects ( ) in the single-chromosome2f
analyses captures the variation due to the other autosomes
not fitted—for all 22 estimates, the sum of the estimates
of and was ∼0.459, the observed overall sibling2 2f (1/2)h
correlation. Very similar estimates and test statistics were
obtained from a full model with 22 additive genetic-var-
iance components, from which chromosomal heritabili-
ties were dropped one by one (table 1), consistent with
the absence of any large between-chromosome epistatic
effects.
We estimated variance on the X chromosome separately
from the autosomes and separately for brother-brother,
sister-sister, and brother-sister pairs, because the expected
additive genetic covariance between siblings depends on
their sex and on assumptions regarding dosage compen-
sation.20 There was no evidence of additive genetic vari-
ance for height on the X chromosome for all three groups.
The estimates of the proportion of variance due to additive
effects on the X chromosome was 0.007 in brother-brother
pairs ( ), 0.081 in sister-sister pairs ( ), andPp .47 Pp .39
0.00 in brother-sister pairs ( ).Pp .50
Figure 1 shows the relationship between the genetic
length of the chromosome and the estimate of the pro-
portion of additive genetic variance attributed to it in the
single-chromosome analyses. In general, the longer the
chromosome, the more variation it explains. A weighted
least-squares regression was performed, with use of the
empirical variance of chromosomal additive coefficients
as weights, because this variance is inversely proportional
to the sampling variance of the estimate of heritability.10
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Figure 1. Estimate of chromosomal heritability from a joint anal-
ysis of all 22 autosomes (labeled on graph) as a function of the
genetic length of the chromosome. The figure shows that there is
a relationship between the genetic length of a chromosome and
the amount of variance it explains. for the regressionP ! .0001
coefficient from a weighted least-squares analysis if no intercept
is fitted. if an intercept is fitted after the regression.Pp .683
Figure 2. Relationship between heritability estimates from the
AU and US data sets. There is a highly significant correlation
between the estimates of chromosomal heritability from the two
data sets (no-intercept model, ; model with intercept,P ! .0001
). The relationship remains significant when conditioningPp .009
on the length of the chromosome (partial correlation 0.540;
, two-sided).Pp .011
The relationship was highly statistically significant in a
no-intercept model (F test, ), and adding an in-P ! .0001
tercept after the regression was not statistically significant
( ). The slope of the regression line (0.03 herita-Pp .683
bility per 100 cM) is consistent with what would be ex-
pected if variance were apportioned according to genetic
length, with the assumption of 0.86 for the overall heri-
tability and a total sex-averaged map length of 2,864 cM
for the autosomes.17 The correlation ( ) betweenrp 0.23
our estimates of chromosomal heritability and the num-
ber of genes per chromosome, obtained from Ensembl
build 36, was smaller than the correlation with chromo-
somal length. The estimates and log-likelihoods of models
in which all 22 additive genetic components were fitted
were compared with those for the model in which a single
genomewide additive genetic component was fitted. The
drop in the log-likelihood of the data was 19.2 ( ,Pp .57
x2 test with 21 df), which means that the more parsi-
monious model of variance contributed by chromosomes
proportional to their length was not rejected.
What is the minimum number of chromosomes needed
to explain genetic variance for height? To address this
question, we ordered chromosomes according to the
amount of genetic variance they explained from the joint
analysis (table 1) and, in a stepwise procedure, added one
chromosome at a time. We compared the log-likelihoods,
stopping when the addition of an extra chromosome did
not improve the fit after accounting for the number of
parameters in the model. To compare models, we used
Akaike’s information criterion (AIC), calculated as2(dif-
ference in log-likelihood) 2(number of additive genetic-
variance components), between the model and the null
model of no additive genetic-variance components. In all
models, a nongenetic family effect ( ) was fitted. The best2f
and most parsimonious model, based on AIC, includes six
chromosomes: 17, 4, 3, 18, 15, and 8, in order of statistical
significance. The scaled AIC values for fitting 1–8 chro-
mosomes were 7.02, 10.41, 13.73, 15.35, 16.36,
19.09,19.03, and18.51, with a minimum of six fitted
genetic-variance components. Hence, our data indicate
that at least 6 but as many as 22 chromosomes may con-
tribute to additive genetic variation for height. For inter-
nal validation, we estimated the proportion of additive
genetic variance attributable to each chromosome sepa-
rately for the two largest data sets (AU and US). Figure 2
shows that the estimates are positively correlated. The
slope of the regression line for the 22 pairs of heritability
estimates in a no-intercept model is close to unity (0.96)
and is highly significantly different from zero ( ),P ! .0001
which indicates that the estimates are generally similar
across the two data sets. The partial correlation between
the heritability estimates after conditioning on the length
of the chromosome remained positive and significant
(partial ; , two-sided), supporting therp 0.54 Pp .011
consistency of heritability estimates across data sets. Var-
iable heritability estimates between chromosomes in ex-
cess of sampling variation imply that chromosomes do
not contribute equally to additive genetic variance, even
after an adjustment for their length.
We next investigated whether the proportion of vari-
ance explained by an autosome in our data is correlated
with the number of times that suggestive or significant
linkage21 has been reported for that chromosome in the
literature, excluding reports that are partially or wholly
based on the data in this study. For each chromosome,
the number of LOD scores 11.9, defined as being “sug-
gestive” of linkage,21 were counted from reported whole-
genome linkage scans for height.22–30 From these scans,
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there were 2, 7, 5, 2, and 6 chromosomes for which 0, 1,
2, 3, and 4 linkages were reported, respectively, for an
average of 2.1 linkages per autosome. We found a positive
and significant correlation between our estimate of chro-
mosomal heritability and the number of reported linkages
from independent studies (Spearman’s nonparametric
rank correlation 0.586; , one-tailed). This rela-Pp .002
tionship remained significant after a linear adjustment of
the latter for the length of the chromosome ( ).Pp .013
For three of the six most significant chromosomes in our
data—namely, 3, 4, and 15—there have been at least three
independent reports of suggestive or significant linkage,
although, for our most significant chromosome (17), there
has been only a single report of suggestive linkage in the
literature. Counting the number of peak LOD scores from
the literature may be an inaccurate quantification of as-
sessing the importance of individual chromosomes in ex-
plaining variation because of reporting bias and because
more false-positive results are likely to be reported for
longer chromosomes. Nevertheless, even after an adjust-
ment for chromosome length and despite the large sam-
pling errors of estimates, we found a significant (but not
perfect) relationship between our estimates of chromo-
somal heritability and the number of times suggestive or
significant linkage had been reported.
To our knowledge, this is the first attempt to attribute
additive genetic variation for a complex trait in humans
to specific chromosomes by partitioning the total vari-
ance. We estimate that additive genetic variation for height
in humans is contributed by all autosomes, with a mini-
mum of six that are responsible, and that there is no sig-
nificant evidence against the hypothesis that all chro-
mosomes contribute to genetic variance in proportion to
their length. For five of these (chromosomes 3, 4, 8, 15,
and 18), there have been multiple independent reports of
linkage in the literature.
Estimates of the effects of individual chromosomes on
variation in a quantitative trait have been reported for
Drosophila,31,32 and a method to estimate variance associ-
ated with whole chromosomes was proposed for experi-
mental line crosses.33 For human pedigrees, a method to
estimate the contribution of chromosome regions or
whole chromosomes to variation in a quantitative trait,
by the estimation of IBD sharing of sibling pairs from
(sparse) marker data, was described elsewhere.34 The prin-
ciple of genome partitioning and whole-genome analysis,
as a multistage approach toward individual QTL mapping,
was proposed by Schork.11 We have performed the first
large-scale application of such methods to the quantitative
trait height and have shown how additive genetic variance
in three populations is distributed over chromosomes.
If indeed all chromosomes contribute variance in pro-
portion to their length, then the best-case scenario for
gene mapping is that all of them harbor a single QTL. For
such an “average” QTL that explains, say, 3.9% (∼0.90 of
23) of the phenotypic variance, a linkage study with
57,830 sib pairs would be needed to detect it with a prob-
ability of 0.80 at a type I error rate of 0.0001.35 This is
much larger than the sample sizes in all reported ge-
nomewide linkage studies for height in humans. The larg-
est study comprises data from ∼4,000 equivalent full-sib
pairs plus 110,000 more-distantly related (and therefore
less informative) relative pairs, with approximately suffi-
cient power to detect QTLs explaining 10% of the phe-
notypic variance in a genome linkage scan.13 A number
of genome linkage scans have been reported with smaller
sample size (typically !1,000 sibling pairs), and a number
of loci, notably those on chromosome 9 and on the X
chromosome, appear to be “replicated.”14,24–27 There is no
evidence of genetic variation associated with chromosome
9 or with the X chromosome in our study. The study by
Liu et al.,13 who reported significant linkage results on
chromosomes 9 and X, was based on large extended ped-
igrees, whereas, in our study, we have extracted the linkage
information from only the full-sibling pairs from that sam-
ple. Large pedigrees contain many more contrasts between
relatives and therefore have more power to detect a QTL
than does an analysis based on the full-sib pairs only. Sta-
tistical replication in linkage studies for complex traits is
problematic because of the imprecision with which loci
are mapped.36 Most of the reported studies, apart from that
by Liu et al.,13 are characterized by small sample size and
by analysis of data for males and females separately,
thereby effectively creating even smaller samples. There
is some evidence of a sex-by-genotype interaction for
height in humans,37,38 but the additive genetic correlation
across the sexes is ∼0.8–0.9,38 so we would expect that
most trait loci have similar effects in males and females.
From the brother-brother, sister-sister, and brother-sister
correlations in our data—0.494, 0.479, and 0.435, respec-
tively—and with the assumption of a pure additive model
of family resemblance, we estimate a genetic correlation
coefficient across the sexes of 0.435/(0.494# 0.479)p
.0.894
Our results have implications for GWA studies for height
and other complex traits, including disease. GWA studies
are typically powered to detect loci that explain at least
0.5%–1% of the phenotypic variation. If the total genetic
variance explained per chromosome is ∼5%, this puts an
upper bound to the effect sizes that can be detected. Many
complex traits, including most diseases, have lower heri-
tabilities than that of height, typically 30%–50%; so, if the
genetic variance for these complex traits is distributed over
all chromosomes, individual chromosomes will explain
only of the order of 1%–3% of the phenotypic variation.
Further, if the partitioning of variation across chromo-
somes, implying many trait loci, can be extrapolated to
the partitioning of variation on an individual chromo-
some (for which we currently have no evidence), then the
effect sizes at individual loci or over small intervals may
become too small to be detected. In the near future, we
will be able to test these hypotheses for quantitative traits,
using GWA studies that are currently being conducted.
From our study, we predict that, if GWA studies of height
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are successful in locating significant loci, then the asso-
ciated variants are likely to be on chromosomes 3, 4, 8,
15, 17, and 18.
The main limitation of our study, as in most studies of
the genetics of complex traits in humans, is sample size.
Despite having a sample of 111,000 sibling pairs with ge-
nomewide marker data and a highly heritable phenotype,
we have insufficient power to estimate precisely the con-
tribution of each chromosome to genetic variance and to
estimate nonadditive genetic variance. However, since
height is a phenotype that is easy to measure and is col-
lected in many cohort studies, and since researchers are
willing to collaborate to increase sample size, it should be
feasible in the near future to further dissect quantitative
genetic variation for height by linkage and/or by associ-
ation with the use of sample sizes of tens of thousands of
individuals.
In conclusion, with a large sample size of 11,214 sibling
pairs, we estimated how genetic variance is apportioned
in the genome. The hypothesis that chromosomes explain
additive genetic variance in proportion to their length
could not be rejected in our data. Despite the recent sug-
gestion that variation due to epistasis is too-often ne-
glected in complex-trait studies,39 we found no evidence
of any nonadditive genetic variance for height, the com-
plex trait we studied. Our results imply, at least for the
quantitative trait height in humans, that genetic variation
can be explained by many loci distributed over all the
autosomes with an additive mode of gene action.
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